Photo of Kristin R. Knight, M.S., C.C.C.-A.

Kristin R. Knight M.S., C.C.C.-A.

    • Associate Professor of Pediatrics School of Medicine
    • LEND Audiology Training Coordinator Institute on Development and Disability School of Medicine

Ms. Knight is proud to see patients at the Child Development and Rehabilitation Center (CDRC).

Ms. Knight specializes in the diagnosis and management of hearing loss in infants, children, and adolescents and she is the Audiology Training Coordinator for the Oregon LEND Program. She grew up in Oregon and has worked at OHSU since 1999. Her research interests involve the detection of hearing loss due to platinum chemotherapy and long-term outcomes of children who acquire hearing loss from platinum treatment. In her spare time Kristy enjoys hiking, camping, gardening, and spending time with family and friends. 

Education

  • M.S., Portland State University, Portland Oregon 1995
  • Certifications:

    • CCC-A, FAAA

Memberships and associations

  • American Speech-Language Hearing Association
  • American Academy of Audiology
  • Children's Oncology Group Auditory Late Effects Committee
  • American Auditory Society

Publications

  • "Ototoxicity in children with high-risk neuroblastoma" Journal of Clinical Oncology February 20 2014
  • "Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption" Pediatric Blood and Cancer August 2006
  • "Early changes in auditory function as a result of platinum chemotherapy" Journal of Clinical Oncology April 1 2007
  • "Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system" Cancer February 1 2008
  • "Ototoxicity in children receiving platinum chemotherapy" Journal of Clinical Oncology  2005
  • "Cerebrospinal fluid shunting and hearing loss in patients treated for medulloblastoma" Journal of neurosurgery. Pediatrics April 2012
  • "Hearing loss in pediatric cancer survivors treated with cisplatin." ONCOLOGY (United States) April 2008
  • "Platinum-induced ototoxicity in children" Journal of Clinical Oncology July 1 2012
  • "Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers" Pediatric Blood and Cancer  2016
  • "Assessment of DPOAE test-retest difference curves via hierarchical Gaussian processes" Biometrics  2016
  • "Patient-reported measures of hearing loss and tinnitus in pediatric cancer and hematopoietic stem cell transplantation" Journal of Speech, Language, and Hearing Research October 1 2016
  • "Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431)" The Lancet Oncology January 1 2017
  • "Ototoxicity monitoring in children treated with platinum chemotherapy" International Journal of Audiology July 21 2017
  • "Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1)" Journal of Clinical Oncology February 1 2017
  • "Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors" The Lancet Oncology January 1 2019
  • "Interventions for cisplatin-induced hearing loss in children and adolescents with cancer" The Lancet Child and Adolescent Health August 1 2019

Additional information

Edit profile